Charles River Laboratories Announces Third-Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Charles River Laboratories (CRL) Tops Q3 EPS by 6c, Updates Guidance
November 6, 2019 7:13 AM ESTCharles River Laboratories (NYSE: CRL) reported Q3 EPS of $1.69, $0.06 better than the analyst estimate of $1.63. Revenue for the quarter came in at $668 million versus the consensus estimate of $672.74 million.
GUIDANCE:
Charles River Laboratories sees FY2019 EPS of $6.50-$6.60, versus... More
